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ABSTRACT—Arrhythmia is a big headache for cardiologist for a long time. A new antiarrythmic drug with good effects and 
few side effects should be explored. Hydrogen sulfide, a newly found gaseous transmitter, was found to have multi-effects 
on a variety of ion channels. It may be a promising antiarrythmic drug. This article reviews the different effects of hydrogen 
sulfide on different ion channels.
Ion  channels  initiate  and  conduct  electrical  activity  in  the 
heart. The channels open and close in response to changes in 
membrane  potential,  and  allow  ionic  permeation  across  the 
plasma membrane. The idea that defective ion channels might 
be  responsible  for  cardiac  arrhythmia  has  received  indirect 
support from the anti- or proarrhythmic actions of a host of 
drugs and toxins that are specific for Na+, Ca2+ and K+ channels. 
With the progress of the clinical trials, it is widely understood 
that drugs having multi-effects on various ion channels may be 
the promising antiarrhythmic drug
Antiarrhythmic drugs today
Recently, cardiologists are more interested in devices and ablation 
techniques for arrhythmia treatment than in pharmacological 
treatment.  However,  pharmacological  treatment  is  still  very 
important  especially  in  prevention  of  atrial  fibrillation  and 
sudden cardiac death.
It  is  well  known  that  present  antiarrhythmic  drugs  are 
not ideal. They induce another arrhythmia when treating one 
arrhythmia or increased the total death rate although inhibited 
arrhythmia.  Therefore,  new  antiarrhythmic  drugs  are  still 
welcome.
To date, the most popular antiarrhythmic drug classification 
is the system developed by Singh and Vaughan Williams1 in the 
early 1970s and subsequently modified by Singh and Hauswirth 
and by Harrison.2 In this system, antiarrhythmic drugs were 
divided into class I for sodium-channel blockade (with subclasses 
IA, IB and IC), class II for adrenergic antagonism, class III for 
action-potential prolongation, and class IV for calcium-channel 
blockade. Among these drugs, since the publication of studies 
demonstrating that certain drugs may increase mortality in high-
risk post-infarction patients,3 basic science and clinical studies 
have focused on Class III antiarrhythmic drugs. However, Class 
III  drugs  prolong  repolarization  and  cardiac  refractoriness, 
and are sometimes associated with potentially lethal Torsades 
de pointes. Amiodarone, a multichannel blocker, may be the 
exception to this observation. Therefore, both cardiologists and 
pharmacologists are turning their interests towards developing 
new multichannel blocker, since amiodarone nevertheless fails 
to reduce total mortality compared with placebo in high-risk 
patients following myocardial infarction.4
Hydrogen sulfide—a potent multichannel acting 
antiarrhythmic drug -
Recent  studies5,  6  showed  that  hydrogen  sulfide  (H2S),  new 
gaseous  transmitter,  acted  on  several  cardiac  ion  channels, 
inhibited arrhythmia and prevented ischemia-reperfusion injury. 
It is reasonable to think of it as a potent promising multichannel 
acting antiarrhythmic drug.
H2S has been best known for decades as the toxic gas or 
‘gas of rotten eggs’. It has been founded as a new gaseous 
transmitter only in recent years.7 And from 2003, H2S has been 
widely studied in different pathological animals. Most of these 
studies showed that H2S exerts its function through acting on 
different ion channels.8,9
Effects of H2S on ATP dependent  
potassium channel (KATP)
The first study10 about the action of H2S on ion channels was 
from  Zhao’s  study,  and  they  studied  the  effects of  H2S  on 
KATP. They proved the opening effect of H2S on KATP channel 
through three different levels. First, they found blood pressure 
decreasing effect of H2S was antagonized by blockade of KATP 
channels. Then their results showed H2S relaxed rat aortic in vitro 
in a KATP channel-dependent manner. Finally, they proved with 
patch clamp technique that H2S increased KATP channel currents. 
After that, Geng et al11 found H2S has negative inotropic effect 
through opening KATP channel. Zhang and colleagues5 did an 
even more interesting study. They made an ischemia-reperfusion 
model  in  vitro  by  Langendorff  apparatus.  They  found  H2S 
had  a  cardioprotective  effect  against  ischemia-reperfusion 
injury. Moreover, they found H2S decreased arrhythmia score 
significantly in this model. Through patch-clamp technique, they 
also found that cardioprotective mechanism of H2S was opening 
of KATP channel. Zhang’s results challenged the traditional point 
of view, i.e. shortening of repolarization of cardiac cells due 
to opening of potassium channel may shorten the refractory 
period and induce arrhythmia. This may be explained by the 
following mechanisms: 1) Although H2S shortened refractory 
period of ventricular myocardial cells, it prolonged the effective 
refractory period relatively; 2) H2S has greater effects on other 
ion channels.Hydrogen Sulfide—a potent multichannel anti-arrhythmic drug
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To further explore the mechanism of H2S on KATP, Zhang et 
al.12 studied the effect of H2S on gene and protein expression 
of  KATP  (SUR2B  mRNA  and  Kir  6.1mRNA).  Their  results 
showed that H2S increased the gene expression of KATP as well 
as the protein expression.
Effects of H2S on Calcium channel
The first study that may involve L-Calcium channel is from 
Geng’s work.11 Both in vivo and in vitro experiments in this 
study proved that H2S had a negative inotropic effect on rat 
heart. This may suggest the effect of H2S on L-calcium channel, 
although the authors did not perform any related experiments.
As researchers focused on the effect of H2S on KATP channel, 
Xiao et al13 noticed another channel—L-calcium channel was 
also involved in the acting mechanism of H2S. They studied 
the effect of H2S on the functional curve of baroreflex. The 
results showed H2S facilitated the carotid sinus baroreceptor. 
Pretreatment with a KATP channel blocker, abolished the above 
effects  while  pretreatment  with  Bay  K8644  (an  agonist  of 
calcium channels) eliminated the effect of H2S on carotid sinus 
baroreceptor. Therefore, they concluded that H2S opened KATP 
channels and further closed the calcium channels.
The above study is on carotid sinus baroreceptor, which may 
be quite different from myocardial cells. Yet, Xu and colleagues14 
studied the effect of H2S on L-calcium channel on guinea pig 
papillary muscles. Their data showed that pretreatment with 
L-type Ca2+ channel agonist Bay K8644 partially blocked the 
effects  of  NaHS  (a  H2S  donor),  which  suggested  that  the 
reduction of calcium influx may also contribute to the effects of 
H2S. Furthermore, they found that pretreatment with Ca2+-free 
K-H solution containing Glibenclamide completely blocked the 
effects of H2S, which indicated that the effects of H2S guinea 
pig papillary are due to the changes of potassium and calcium 
currents.
Step  further,  Sun  et  al15  studied  the  effects  of  H2S  on 
L-Calcium channel directly, and stated definitely that Hydrogen 
sulphide is an inhibitor of L-type calcium channels. Sun and 
colleagues found a concentration-dependent inhibition of peak 
ICa.L on cardiomyocytes by NaHS (a H2S donor). It becomes 
clear that H2S has an inhibitory effect on L-Calcium channel. 
However, the mechanism needs further study.
Although, no study was reported about the H2S on T type 
Calcium channel on cardiomyocytes, Nagasawa et al.16 studied 
the effect of H2S on T-type calcium channels on NG 108-15 
cells (which may be differentiated into neuronal cells). Their 
study showed H2S could stimulate the T-type calcium channels. 
Therefore, it is reasonable to think of H2S as having an effect 
on T-type calcium channels, which needs further exploration.
Effects of H2S on chloride channel
Chloride  channels  are  important  for  setting  cell  resting 
membrane potential and maintaining proper cell volume. These 
channels conduct Cl− as well as other anions such as HCO3−, 
I−, SCN−, and NO3−. Chloride channels display a variety of 
important physiological and cellular roles that include regulation 
of  pH,  volume  homeostasis,  organic  solute  transport,  cell 
migration, cell proliferation and differentiation. Recent studies 
have  identified  several  chloride  (Cl−)  channel  genes  in  the 
heart, including CFTR, ClC−2, ClC−3, CLCA, Bestrophin, and 
TMEM16A. It has been shown that Cl− channels may contribute 
to cardiac arrhythmogenesis, myocardial hypertrophy and heart 
failure, and cardioprotection against ischaemia–reperfusion.17
Since the reason above, we are concerned of the effect of 
H2S on chloride channel. The effect is reported on June 2009 
by Malekova et al.9, where they derived single chloride channels 
from the rat heart lysosomal vesicles incorporated into a bilayer 
lipid membrane. Their results showed that H2S inhibited the 
chloride channels by decreasing the channel open probability 
in a concentration-dependent manner. Since they incorporated 
the single chloride channels into the bilayer lipid membrane, 
they measured the IC50 for tans and the cis sides, respectively 
and got the different results (42uM vs. 75uM).
Beneficial cardiac effects from H2S
With the results of the famous CAST clinical trial,3 people 
realized  that  benefits  for  the  patient’s  prognosis  is  more 
important than antiarrhythmia itself. So the effect of H2S on 
the whole heart may be more important.
The effect on the whole heart was first described in Geng’s 
study18 Their results showed that administration of exogenous 
H2S effectively protects cardiomyocytes and contractile activity 
from isoproterenol injury. Then, Zhang et al5 isolated rat heart, 
then  made  an  ischemia-reperfusion  model  with  langendorff 
apparatus.  The  results  showed  that  the  treatment  of  hearts 
with a H2S donor during reperfusion resulted in a significant 
improvement  in  heart  function  and  the  arrhythmia  scores 
was  also  improved.  Furthermore,  Sivarajah  et  al.19  found  in 
the ischemia-reperfusion model that the antiapoptotic effect 
of NaHS (H2S donor) may be in part due to the opening of 
the  putative  mitochondrial  adenosine  triphosphate-sensitive 
potassium channels.
CONCLUSION
In summary, H2S has various effects on various ion channels 
from cardiomyocytes. Not only can it improves heart arrhythmia 
score,  but  also  can  protect  heart  from  ischemia-reperfusion 
injury and has beneficial effects on the heart function. We have 
reasons to think of it as a promising antiarrhythmic drug. Since 
it was a newly found endogenous gaseous signaling molecule, 
the risk, safety issues, dosage, proposed delivery methods and 
so on are therefore a big field to be explored.
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